ATE400813T1 - Tumormarker für frühes krebsstadium - Google Patents

Tumormarker für frühes krebsstadium

Info

Publication number
ATE400813T1
ATE400813T1 AT00957049T AT00957049T ATE400813T1 AT E400813 T1 ATE400813 T1 AT E400813T1 AT 00957049 T AT00957049 T AT 00957049T AT 00957049 T AT00957049 T AT 00957049T AT E400813 T1 ATE400813 T1 AT E400813T1
Authority
AT
Austria
Prior art keywords
early stage
tumor markers
stage cancer
urine
blood
Prior art date
Application number
AT00957049T
Other languages
English (en)
Inventor
Takashi Muramatsu
Kohji Okamoto
Shinya Ikematsu
Munehiro Oda
Hideshi Kumai
Sadatoshi Sakuma
Original Assignee
Takashi Muramatsu
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takashi Muramatsu filed Critical Takashi Muramatsu
Application granted granted Critical
Publication of ATE400813T1 publication Critical patent/ATE400813T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5758—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/475—Assays involving growth factors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT00957049T 1999-09-10 2000-09-08 Tumormarker für frühes krebsstadium ATE400813T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP25667899 1999-09-10
JP34540499 1999-12-03
JP2000033168 2000-02-10

Publications (1)

Publication Number Publication Date
ATE400813T1 true ATE400813T1 (de) 2008-07-15

Family

ID=27334550

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00957049T ATE400813T1 (de) 1999-09-10 2000-09-08 Tumormarker für frühes krebsstadium

Country Status (9)

Country Link
US (1) US7090983B1 (de)
EP (1) EP1215500B1 (de)
KR (1) KR100768985B1 (de)
CN (1) CN1232826C (de)
AT (1) ATE400813T1 (de)
AU (1) AU780957B2 (de)
CA (1) CA2384579C (de)
DE (1) DE60039441D1 (de)
WO (1) WO2001020333A1 (de)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003301348A1 (en) * 2002-10-18 2004-05-04 Wyeth Compositions and methods for diagnosing and treating autoimmune disease
GB0307428D0 (en) 2003-03-31 2003-05-07 Medical Res Council Compartmentalised combinatorial chemistry
GB0307403D0 (en) 2003-03-31 2003-05-07 Medical Res Council Selection by compartmentalised screening
US20060078893A1 (en) 2004-10-12 2006-04-13 Medical Research Council Compartmentalised combinatorial chemistry by microfluidic control
WO2004092992A1 (ja) * 2003-04-15 2004-10-28 Cell Signals Inc. 健康情報の提供システムおよび健康情報の提供方法
US20050221339A1 (en) 2004-03-31 2005-10-06 Medical Research Council Harvard University Compartmentalised screening by microfluidic control
US7968287B2 (en) 2004-10-08 2011-06-28 Medical Research Council Harvard University In vitro evolution in microfluidic systems
WO2007053659A2 (en) * 2005-11-01 2007-05-10 Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services Method of screening for hepatocellular carcinoma
EP2363205A3 (de) 2006-01-11 2014-06-04 Raindance Technologies, Inc. Mikrofluidische Vorrichtungen Und Verfahren Zur Verwendung Bei Der Bildung Und Kontrolle Von Nanoreaktoren
KR100777088B1 (ko) 2006-04-04 2007-11-28 재단법인 한국원자력의학원 간암을 진단하기 위한 마커인 ｌｃｎ2, ｍｉｄｋｉｎｅ 및ｔｆｐｉ, 그를 포함하는 키트 및 상기 마커를 이용한 간암예측 방법
EP2530168B1 (de) 2006-05-11 2015-09-16 Raindance Technologies, Inc. Mikrofluidische Vorrichtungen
US9562837B2 (en) 2006-05-11 2017-02-07 Raindance Technologies, Inc. Systems for handling microfludic droplets
EP2077912B1 (de) 2006-08-07 2019-03-27 The President and Fellows of Harvard College Fluorkohlenstoffemulsionsstabilisierende tenside
US8772046B2 (en) 2007-02-06 2014-07-08 Brandeis University Manipulation of fluids and reactions in microfluidic systems
WO2008130623A1 (en) 2007-04-19 2008-10-30 Brandeis University Manipulation of fluids, fluid components and reactions in microfluidic systems
JPWO2009025094A1 (ja) * 2007-08-20 2010-11-18 大野　典也 哺乳動物の癌の診断方法
WO2009067546A2 (en) * 2007-11-19 2009-05-28 Celera Corpration Lung cancer markers and uses thereof
CN101960308B (zh) * 2008-02-29 2014-07-09 国立大学法人名古屋大学 急性肾损伤及预后推测用生物标记物以及其用途
WO2010009365A1 (en) 2008-07-18 2010-01-21 Raindance Technologies, Inc. Droplet libraries
US12038438B2 (en) 2008-07-18 2024-07-16 Bio-Rad Laboratories, Inc. Enzyme quantification
US10359425B2 (en) * 2008-09-09 2019-07-23 Somalogic, Inc. Lung cancer biomarkers and uses thereof
US20100221752A2 (en) * 2008-10-06 2010-09-02 Somalogic, Inc. Ovarian Cancer Biomarkers and Uses Thereof
JP2010139293A (ja) * 2008-12-10 2010-06-24 Medical Therapies Ltd 早期癌腫瘍マーカー
US8528589B2 (en) 2009-03-23 2013-09-10 Raindance Technologies, Inc. Manipulation of microfluidic droplets
WO2010143423A1 (ja) * 2009-06-10 2010-12-16 国立大学法人 新潟大学 糖尿病性腎症の検査方法
US10520500B2 (en) 2009-10-09 2019-12-31 Abdeslam El Harrak Labelled silica-based nanomaterial with enhanced properties and uses thereof
EP2517025B1 (de) 2009-12-23 2019-11-27 Bio-Rad Laboratories, Inc. Verfahren zur reduzierung des austauschs von molekülen zwischen tröpfchen
US9366632B2 (en) 2010-02-12 2016-06-14 Raindance Technologies, Inc. Digital analyte analysis
US10351905B2 (en) 2010-02-12 2019-07-16 Bio-Rad Laboratories, Inc. Digital analyte analysis
JP5934657B2 (ja) 2010-02-12 2016-06-15 レインダンス テクノロジーズ， インコーポレイテッド デジタル検体分析
US9399797B2 (en) 2010-02-12 2016-07-26 Raindance Technologies, Inc. Digital analyte analysis
MX2012014268A (es) 2010-07-09 2013-02-12 Somalogic Inc Biomarcadores de cancer de pulmon y usos de los mismos.
EP2603622A4 (de) 2010-08-13 2015-04-22 Somalogic Inc Biomarker für bauchspeicheldrüsenkrebs und verwendungen davon
WO2012045012A2 (en) 2010-09-30 2012-04-05 Raindance Technologies, Inc. Sandwich assays in droplets
NZ589251A (en) * 2010-11-12 2014-07-25 Pacific Edge Ltd Novel marker for detection of bladder cancer
EP3859011A1 (de) 2011-02-11 2021-08-04 Bio-Rad Laboratories, Inc. Verfahren zur bildung gemischter tröpfchen
EP2675819B1 (de) 2011-02-18 2020-04-08 Bio-Rad Laboratories, Inc. Zusammensetzungen und verfahren für molekulare etikettierung
US8841071B2 (en) 2011-06-02 2014-09-23 Raindance Technologies, Inc. Sample multiplexing
DE202012013668U1 (de) 2011-06-02 2019-04-18 Raindance Technologies, Inc. Enzymquantifizierung
US8658430B2 (en) 2011-07-20 2014-02-25 Raindance Technologies, Inc. Manipulating droplet size
WO2013120089A1 (en) 2012-02-10 2013-08-15 Raindance Technologies, Inc. Molecular diagnostic screening assay
EP2844768B1 (de) 2012-04-30 2019-03-13 Raindance Technologies, Inc. Digitale analyse von analyten
US9946887B2 (en) 2012-06-04 2018-04-17 Nokia Technologies Oy Method and apparatus for determining privacy policy based on data and associated values
CN104956224B (zh) 2012-11-20 2017-12-12 美国政府卫生与公共服务部 测量中期因子或多效生长因子水平用于诊断生长的测定
US20140271453A1 (en) * 2013-03-14 2014-09-18 Abbott Laboratories Methods for the early detection of lung cancer
EP2986762B1 (de) 2013-04-19 2019-11-06 Bio-Rad Laboratories, Inc. Digitale analyse von analyten
US11901041B2 (en) 2013-10-04 2024-02-13 Bio-Rad Laboratories, Inc. Digital analysis of nucleic acid modification
US9944977B2 (en) 2013-12-12 2018-04-17 Raindance Technologies, Inc. Distinguishing rare variations in a nucleic acid sequence from a sample
US11193176B2 (en) 2013-12-31 2021-12-07 Bio-Rad Laboratories, Inc. Method for detecting and quantifying latent retroviral RNA species
CN106461678A (zh) * 2014-05-26 2017-02-22 奥林巴斯株式会社 胰腺癌判定方法
US10647981B1 (en) 2015-09-08 2020-05-12 Bio-Rad Laboratories, Inc. Nucleic acid library generation methods and compositions
US10998178B2 (en) 2017-08-28 2021-05-04 Purdue Research Foundation Systems and methods for sample analysis using swabs
CN109387635A (zh) * 2018-11-07 2019-02-26 国家纳米科学中心 基于热泳细胞外囊泡检测的胃癌检测系统及方法
KR20220000082U (ko) 2020-07-01 2022-01-10 박세현 곽 휴지 형 그림책

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3418416B2 (ja) * 1992-10-08 2003-06-23 喬 村松 核酸診断法
JP3842304B2 (ja) * 1992-10-08 2006-11-08 喬 村松 癌の診断、治療薬
WO2000031541A2 (en) * 1998-11-20 2000-06-02 Georgetown University Method of detecting neurofibromatosis type 1

Also Published As

Publication number Publication date
DE60039441D1 (de) 2008-08-21
WO2001020333A1 (en) 2001-03-22
CN1390304A (zh) 2003-01-08
CA2384579A1 (en) 2001-03-22
CA2384579C (en) 2010-12-07
KR100768985B1 (ko) 2007-10-22
CN1232826C (zh) 2005-12-21
EP1215500A1 (de) 2002-06-19
EP1215500B1 (de) 2008-07-09
US7090983B1 (en) 2006-08-15
AU780957B2 (en) 2005-04-28
AU6876000A (en) 2001-04-17
EP1215500A4 (de) 2004-12-08
KR20020043577A (ko) 2002-06-10

Similar Documents

Publication Publication Date Title
EP1215500A4 (de) Tumormarker für frühes krebsstadium
ATE314651T1 (de) Tumormarker
WO2006081473A3 (en) Methods for diagnosis and prognosis of epithelial cancers
ATE440629T1 (de) Kanüleneinführungssystem
ATE322014T1 (de) Krebsnachweisverfahren und reagenzien
WO2004060302A3 (en) Methods and compositions for the diagnosis, prognosis, and treatment of cancer
SI1535068T1 (sl) Naprave in postopki za odkrivanje amnijske tekočine v vaginalnih izločkih
ATE528652T1 (de) Analysesystem mit testband
DK1469890T3 (da) Reaktivt paramagnetisk kontrastmiddel til magnetresonansbilledteknik
DE60041623D1 (de) Körperstützsystem für Patienten
DE50004085D1 (de) Medizinisches, insbesondere chirurgisches instrument
DE60239042D1 (de) Haptene, Immunogene, Antikörper und Konjugate für 2-oxo-3-hydroxy LSD
WO2004112567A3 (en) Methods, device and system for in vivo detection
ATE178357T1 (de) Nachweismethoden für c-raf-1-genes.5
DE69906202D1 (de) Evakuiertes Blutentnahmeröhrchen zur schneller Blutgerinnung
DK1214447T3 (da) Påvisning af pyruvatkinase-isoenzymer i fæces
DK1173766T3 (da) Isoform af tenascin-C som markör for neoplasier
ATE409002T1 (de) Gerät für prostatekrebsdiagnose
ATE311101T1 (de) Abbildung von transgenen markern
ATE277197T1 (de) Nachweis von harnblasenkarzinom in einer urinprobe
EP1115426A4 (de) Verfahren zur diagnose, feststellung, einstufung, darstellung sowie behandlung gynäkologischer krebserkrankungenund hodenkrebs
NO20054142D0 (no) In vitro diagnostisk test for enterovirale infeksjoner
ATE520031T1 (de) Ibc-1 (invasive breast cancer-1), ein bei brustkrebs amplifiziertes mutmassliches onkogen
ES1047268U (es) Funda para estetoscopios.
DE50307427D1 (de) Röntgenkassette mit seitlichem Anschlag für den Bildträger

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties